NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE206325 Query DataSets for GSE206325
Status Public on Jun 16, 2023
Title Intratumoral mregDC and Tfh-like niches enable local reinvigoration of CD8 T cells following PD-1 blockade
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Other
Summary While T cell accumulation in tumors is associated with response to immune checkpoint blockade (ICB), many T cell-rich tumors fail to respond to ICB. Here we leveraged a large neoadjuvant PD-1 blockade trial in hepatocellular carcinoma (HCC) to search for correlates of ICB response within T cell-rich tumors. Paired scRNAseq/TCRseq of nearly one million immune cells revealed that tumor responses to ICB correlated with significant clonal expansion of intratumoral CH25H+CXCL13+IL-21+CD4 T cells and GranzymeK+PD-1+CD8 effector T cells, whereas terminally exhausted CD39hiToxhiPD-1hi CD8 clones dominated in non-responders. Notably, proliferating and progenitor CD8 T cells clones were found in tumors of responders and non-responders. However, tumors from responders were highly enriched in mregDCs, a DC state triggered by capture of tumor debris, which formed physically interacting cellular triads with Tfh-like CD4 and progenitor-like CD8 T cells. Receptor-ligand analysis revealed unique interactions within these triads that may promote progenitor CD8 T cell differentiation into effector cells upon PD-1 blockade. These results suggest that discrete cellular niches that include mregDCs and Tfh-like CD4 T cells might control the differentiation of tumor-specific progenitor CD8 T cell clones into effective anti-tumor T cells in human tumors.
 
Overall design Samples of tumor and non-involved liver were obtained from surgical specimens of patients undergoing resection at Mount Sinai Hospital (New York, NY) after obtaining informed consent in accordance with a protocol reviewed and approved by the Institutional Review Board at the Icahn School of Medicine at Mount Sinai. Cells were counted using the Nexcelom Cellaca. An aliquot of 400,000 cells from each sample were centrifuged at 350g for 5 minutes at 4°C. The supernatant was discarded and the pellets were resuspended in a hashtag antibody solution and incubated on ice for 20 minutes. Hashtag antibodies were conjugated as per New York Genome Center hashing protocol (https://citeseq.files.wordpress.com/2019/02/cell_hashing_protocol_190213.pdf). Stained cells were washed three times in 1mL wash buffer (PBS + 0.5% BSA) by 4°C centrifugation at 350g to remove unbound antibodies. Washed cells were resuspended in 150µl wash buffer and counted using a Nexcelom Cellaca. Hashed samples were pooled and centrifuged at 350g for 5 minutes at 4°C. Supernatant was removed and pellet was resuspended in 100µl of antibody cocktail (Table S4) and incubated at 4°C for 30 minutes. Stained cells were washed three times in 1mL PBS + 0.5% BSA by 4°C centrifugation at 350g to remove unbound antibodies. The washed cells were resuspended in wash buffer to achieve a target concentration of 4 million cells/mL. Sample pool was counted and loaded on the 10x Genomics NextGem 5’v1.1 assay as per the manufacturer’s protocol with a targeted cell recovery of 25,000 cells per lane (CITEseq) or 10,000 cell per lane (direct load). Gene expression and Feature Barcode libraries were made as per the 10x Genomics demonstrated protocol. Hashtag oligonucleotides (HTO) were enriched during cDNA amplification with the addition of 3 pmol of a HTO Additive primer (5’GTGACTGGAGTTCAGACGTGTGCTC). This PCR product was isolated from the mRNA-derived cDNA via SPRISelect size selection, and libraries were made as per the New York Genome Center Hashing protocol. All libraries were quantified via Agilent 2100 hsDNA Bioanalyzer and KAPA library quantification kit (Roche) Gene expression libraries were sequenced at a targeted depth of 25,000 reads per cells. ADT libraries were sequenced at a targeted read depth of 10,000 reads per cell. HTO libraries were sequenced at a targeted read depth of 1,000 reads per cell. Paired-end sequencing was performed on Illumina NovaSeq 6000 for RNA-seq and CITE-seq libraries (for 3’ libraries, used Read 1 28 bp for UMI and cell barcode, Read 2 80-bp for transcript read, with 8-bp i7 and 0-bp i5 reads; for 5’ libraries, used Read 1 26 bp for UMI and cell barcode, Read 2 80-bp for transcript read, with 8-bp i7 and 0-bp i5 reads). V(D)J libraries were also sequenced on Illumina NovaSeq 6000 (Read 1 150-bp, 8-bp i7, 0-bp i5, Read 2 150-bp). Hashtag libraries were sequenced on Illumina NextSeq500.

Human liver tumor samples were collected at baseline biopsy without treatment and after PD-1 Antibody (Cemiplimab) treatment at resection. Tumor tissus were sequenced for TCR.
 
Contributor(s) Merad M, Magen A, Hamon P, Thurston G
Citation(s) 37322116
Submission date Jun 16, 2022
Last update date Mar 01, 2024
Contact name Darwin D'Souza
Organization name Human Immune Monitoring Center
Department ImmunoBio
Street address 1470 Madison Avenue
City New York
State/province NY
ZIP/Postal code 10029
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (510)
GSM6250683 mRNA-derived cDNA Li15_1-G
GSM6250684 ADT-derived cDNA Li15_1-A
GSM6250685 HTO-derived cDNA Li15_1-H
Relations
BioProject PRJNA850077
SRA SRP382175

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE206325_data_SingleCellExperiment_object.Rda.gz 2.3 Gb (ftp)(http) RDA
GSE206325_full_HCC_cluster_annotation.csv.gz 916 b (ftp)(http) CSV
GSE206325_revised_processed_TCR.csv.gz 9.3 Mb (ftp)(http) CSV
GSE206325_sample_annots_Liver_Treated_patients.csv.gz 4.9 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap